Turtle Cameron
5 of 18 shown
The 5 most recent of 18 visible filings, newest first.
- Spyre Therapeutics, Inc. Chief executive officer$9,391Open-market sale
- Spyre Therapeutics, Inc. Chief executive officer$465,916Open-market sale
- Spyre Therapeutics, Inc. Chief executive officer$368,225Open-market sale
- Spyre Therapeutics, Inc. Chief executive officer$241,351Open-market sale
- Spyre Therapeutics, Inc. Chief executive officer$241,738Open-market sale